Back to Market Feed

Product Information

BROMFENAC SODIUM 0.07% EYE DRP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $12.6625 per ML under NDC 62332058303. Its NADAC has been published 106 times since Aug 14, 2024.

FDA first approved this application on Jul 8, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BROMFENAC SODIUM 0.07% EYE DRP

BROMFENAC SODIUM
$12.6625per ML

Strength

.805 mg/mL

NDC

62332058303

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

BROMFENAC SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA214340

FDA Approved

7/8/2024

TE Code

AB

On Market Since

7/8/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for BROMFENAC SODIUM 0.07% EYE DRP has been published 106 times since Aug 14, 2024, and over the history we have for it it has declined 79.4%. The table below summarizes its recorded NADAC range and movement.

Current price$12.6625 per ML
All-time high$68.2970 (Sep 11, 2024)
All-time low$11.7673 (Apr 22, 2026)
52-week high$15.4792
52-week low$11.7673
Median price$15.3018
Average price$19.5085
Largest weekly change-53.9% (Nov 20, 2024)
Weeks tracked106
Tracking sinceAug 14, 2024

Price History

1W

-2.7%

1M

-2.7%

3M

-1.5%

6M

-5.3%

1Y

-18.2%

3Y

N/A

5Y

N/A

All

-79.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BROMFENAC SODIUM market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

MINIPRIN EC 81 MG TABLET
Generic
49483033010•Time-Cap Labs Inc.
$0.0118
per EA
MINIPRIN EC 81 MG TABLET
Generic
49483033012•Time-Cap Labs Inc.
$0.0118
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035203•Chain Drug Marketing Association
$0.0121
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035210•Chain Drug Marketing Association
$0.0121
per EA
ST. JOSEPH ASPIRIN EC 81 MG TB
Generic
69536018112•Foundation Consumer Healthcare LLC
$0.0139
per EA
ASPIRIN EC 81 MG TABLET
Generic
00536123441•Rugby Laboratories
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904675180•Major Pharmaceuticals
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904678370•Major Pharmaceuticals
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059848•AmerisourceBergen
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059887•AmerisourceBergen
$0.0146
per EA

Frequently asked questions

What is the NADAC price of BROMFENAC SODIUM 0.07% EYE DRP?

The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SODIUM 0.07% EYE DRP, manufactured by Alembic Pharmaceuticals Inc., is $12.6625 per ML (NDC 62332058303), effective Aug 19, 2026.

How has the price of BROMFENAC SODIUM 0.07% EYE DRP changed over time?

Over the history we have for it, the NADAC for BROMFENAC SODIUM 0.07% EYE DRP has declined 79.4%. It has been tracked across 106 weekly CMS publications since Aug 14, 2024.

What are the highest and lowest recorded NADAC prices for BROMFENAC SODIUM 0.07% EYE DRP?

Since Aug 14, 2024, the NADAC for BROMFENAC SODIUM 0.07% EYE DRP has ranged from a low of $11.7673 (Apr 22, 2026) to a high of $68.2970 (Sep 11, 2024), with a median of $15.3018 per ML.

Are there cheaper alternatives to BROMFENAC SODIUM 0.07% EYE DRP?

No other NADAC-published product currently shares the active ingredient and strength of BROMFENAC SODIUM 0.07% EYE DRP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BROMFENAC SODIUM 0.07% EYE DRP?

BROMFENAC SODIUM 0.07% EYE DRP (NDC 62332058303) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.